Divalproex Sodium Capsule, Delayed Release
Product Images NDC 55154-3552

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55154-3552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (0816a066 9ee3 4c23 944d 3539fc2c12bf 00)

DIVALPROEX SODIUM DELAYED-RELEASE CAPSULES, USP (SPRINKLE) 125 mg Valproic Acid Activity 10 CAPSULES containing Divalproex sodium USP equivalent to valproic acid 125 mg. The capsules are stored at 20° - 25° G (68° - 77° F). They can be swallowed whole or opened, and the contents can be placed on food for administration. This drug is for Institutional Use Only and should be kept out of the reach of children. For more information on this product, see the insert in the medication guide found at www.majorpharmaceuticals.com.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Picture1 (Picture1)

FDA Label Image

Picture2 (Picture2)

FDA Label Image

Picture3 (Picture3)

FDA Label Image

Picture4 (Picture4)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.